- This event has passed.
2021 Poster Session: A Virtual Experience
July 15, 2021
We have a total of 29 authors/presenters sharing their critical insights and research findings.
Earn up to a max of 7.25 hours of CME depending on how many posters you choose to view.
Instructions on how to access the posters and obtain CME will be included in your confirmation email.
Costs:
- CTMSS Members: $25 USD
- Non-Members: $85 USD
All registrations will be checked for membership.
Acknowledgment of Financial Commercial Support
No financial commercial support was received for this educational activity.
Acknowledgment of In-Kind Commercial Support
No in-kind commercial support was received for this educational activity.
Satisfactory Completion
Learners must review each poster chosen and take up to 15 minutes to absorb the information and complete an evaluation form to receive a certificate of completion.
Complete all posters you wish to view before completing the evaluation.
If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.
Physicians
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Clinical TMS Society. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement – Amedco LLC designates this enduring material for a maximum of 7.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Objectives - After Attending This Program You Should Be Able To
- Identify evidence for various TMS treatment approaches compared to standard TMS approach
- Discuss the effectiveness of TMS in various populations and settings
- Discuss predictive biomarkers and/or clinical markers of response to repetitive transcranial magnetic stimulation (rTMS) treatment
Disclosure of Conflict of Interest
The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-‐6.2, 6.5)
All individuals in a position to control the content of CE are listed on the website. If their name is not listed below, they disclosed that they had no financial relationships with a commercial interest.
| First Name | Last Name | Commercial Interest: Relationship |
| Scott | Aaronson | Neuronetics:Research Grant Site Principal Investigator,Janssen:Consultant,Sage Therapeutics:Consultant,Compass Pathways:Research Grant Site Principal Investigator,Genomind:Scientific/Medical Advisory Board Member,LivaNova:Consultant,Neurolief:Consultant,Neuronetics:Consultant,Compass Pathways:Research Grant Overall Principal Investigator |
| Paul | Croarkin | Neuronetics, Inc:Research Grant Site Principal Investigator,Pfizer, Inc:Research Grant Overall Principal Investigator,Assurerx Health:Other,Procter & Gamble Company:Consultant,Sunovian :Scientific/Medical Advisory Board Member,NeoSync:Research Grant Site Principal Investigator,MagVenture: Equipment Support ,Myriad Neuroscience:Consultant,Engrail Therapeutics:Scientific/Medical Advisory Board Member,Neuronetics:Equipment Support |
| Nancy | Donachie | Smart Health & Wellness Centers:Stock Shareholder,Salience TMS Neuro Solutions:Scientific/Medical Advisory Board Member,Smart Health & Wellness Centers:Scientific/Medical Advisory Board Member |
| David | Dunner | Neuronetics:Other Financial or Material Support/consultant,Cyberonics/Livanova:Other Financial or Material Support/Research support,Janssen:Consultant |
| Todd | Hutton | Neuronetics:Consultant,Southern California TMS Center:Stock Shareholder |
| Joseph | Kriske | Salience TMS Neuro Solutions:Stock Shareholder |
| Adonis | Maiquez | Commercial interest:Own BrainsWay TMS machine |
| Lucian | Manu | Research Funding:Research Grant Site Principal Investigator |
| Leigh | Neal | Smart TMS:Medical Director of Smart TMS |
| Leigh | Neal | Smart TMS:Medical Director of Smart TMS |
| Randy | Pardell | Neuronetics :Co-marketing |
| Randy | Pardell | Neuronetics :Co-marketing |
| Kenny | Perez | SuccessTMS:Consultant |
| Yiftach | Roth | BrainsWay Ltd.:Stock Shareholder |
| Debra | Stultz | Jazz Pharmaceticuls:Speakers Bureau,Harmony Biosciences:Speakers Bureau |
| ARON | TENDLER | Brainsway:Consultant,Brainsway:Stock Shareholder |
| Virtual Poster Session Costs | |
| CTMSS Member | $25.00 |
| Non-Member | $85.00 |
| Complimentary Registration | |
| Registered for Annual Meeting | $0.00 |
| Registered for Live Stream | $0.00 |